Virtual Reality Therapy for Cancer-Treatment Associated Symptoms
Trial Parameters
Brief Summary
We propose an innovative approach to symptom management in cancer patients following cancer treatments, utilizing a Multimodal Integrative Therapy (MIT) delivered via Virtual Reality (VR) program, authorized by the US Food and Drug Administration for in-home use. Our primary goal is to generate pilot data on the effects of MIT-VR program on pain, fatigue, sleep, depression, and anxiety in participants suffering from chronic cancer symptoms following cancer treatments.
Eligibility Criteria
Inclusion Criteria: * Adults ages 18-88 * Cancer diagnosis (histology verified) * Had surgical intervention, completed chemotherapy or radiation for therapeutic purposes -\>3 months since last cancer treatment, but participants currently undergoing endocrine or immunotherapy treatments are permissible * Documented symptoms of cancer or cancer therapy including at least one of the following: pain, anxiety, sleep difficulty, fatigue, neuropathy * English speaker (written and spoken) Exclusion Criteria: * Severe psychiatric condition (e.g. schizophrenia, bipolar disorders, autism) leading to hospitalization within the last 3 years * Any personal (or family first degree) history of mania, schizophrenia, or other psychoses * Diagnosis and treatment of chronic pain, neuropathy, fatigue, sleep or anxiety disorder prior to cancer diagnosis * Current Hospice or palliative care only recipients * Color-blindness * Impaired or uncorrected hearing * Lifetime alcohol/drug dependence or alcohol/drug